A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.

NCT05987358 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

165

Enrollment

INDUSTRY

Sponsor class

Conditions

Biliary Carcinoma

Interventions

DRUG: TQB3454 tablets
DRUG: TQB3454 tablets matching placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.